Across the country, people with metal-on-metal hip implants are dealing with terrible pain on a...READ MORE
Plaintiff Wins $150 Million in AndroGel Lawsuit
An Oregon couple won a $150 million lawsuit against AbbVie Inc., the maker of the testosterone therapy medication AndroGel. The plaintiffs claimed that the man developed severe heart issues after taking the drug and an Illinois jury agreed.
Thousands of Lawsuits
This is one of more than 7,000 lawsuits that have been filed against the makers of medications meant to treat the symptoms of low testosterone, or Low-T. These lawsuits have been consolidated into a multi-district litigation, or MDL, case. It is being heard in the Northern District of Illinois.
Plaintiffs are alleging that manufacturers misled doctors and their patients in an effort to market their testosterone therapy drugs. They allege that these products were advertised in a misleading fashion in an effort to convince middle-aged men there was a solution to their Low-T-related problems, such as constant fatigue and a lack of sex drive.
The Oregon couple claimed that the man decided to take AndroGel after seeing an advertisement. He received a prescription from his doctor and used the drug for four years. It was during this time, he alleged, that he started suffering from heart problems.
They claimed that AbbVie was negligent in developing AndroGel and also misrepresented the benefits of the drug in a fraudulent and negligent manner.